Short Interest in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Grows By 118.5%

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) saw a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 3,586 shares, an increase of 118.5% from the January 15th total of 1,641 shares. Approximately 2.4% of the shares of the company are sold short. Based on an average daily trading volume, of 5,818 shares, the short-interest ratio is presently 0.6 days. Based on an average daily trading volume, of 5,818 shares, the short-interest ratio is presently 0.6 days. Approximately 2.4% of the shares of the company are sold short.

iShares Neuroscience and Healthcare ETF Stock Performance

Shares of iShares Neuroscience and Healthcare ETF stock traded down $0.10 during trading hours on Friday, reaching $31.58. The company’s stock had a trading volume of 721 shares, compared to its average volume of 2,597. The company’s 50 day simple moving average is $32.34 and its 200 day simple moving average is $29.01. The stock has a market cap of $4.74 million, a P/E ratio of 15.61 and a beta of 0.93. iShares Neuroscience and Healthcare ETF has a one year low of $17.86 and a one year high of $37.00.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.